Overview Safety and Efficacy of SH T00660AA in Treatment of Endometriosis Status: Completed Trial end date: 2008-03-01 Target enrollment: Participant gender: Summary The purpose of this study is to demonstrate safety and efficacy of SH T00660AA for the treatment of endometriosis Phase: Phase 3 Details Lead Sponsor: Bayer